Financiën Abbott Laboratories

Aandelen

ABT

US0028241000

Medische apparatuur, benodigdheden & distributie

Beurs gesloten - Nyse Andere beurzen 22:00:02 02-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
116,81 ^USD	-1,65%		-0,81%	+6,12%

25/11	Abbott kondigt de eerste stap aan op weg naar zijn softwaregeleide ballonuitbreidbare TAVI-systeem voor de behandeling van aortastenose	CI
20/11	Insulet Corporation kondigt aan dat het Omnipod® 5-systeem nu compatibel is met de FreeStyle Libre 2 Plus-sensor van Abbott in de V.S.	CI

Voorlopige winst- en verliesrekening: Abbott Laboratories

income-statement-evolution-chart ABBOTT-LABORATORIES

Fiscaal tijdperk: December	2019	2020	2021	2022	2023	2024	2025	2026
Omzet ¹	31.904	34.608	43.075	43.653	40.109	41.998	44.976	48.267
Variatie	-	8,48%	24,47%	1,34%	-8,12%	4,71%	7,09%	7,32%
EBITDA ¹	8.188	9.204	12.815	12.485	10.188	10.655	11.604	12.831
Variatie	-	12,41%	39,23%	-2,58%	-18,4%	4,58%	8,91%	10,57%
Bedrijfsresultaat (EBIT) ¹	7.110	8.009	11.324	11.231	8.911	9.332	10.400	11.502
Variatie	-	12,64%	41,39%	-0,82%	-20,66%	4,73%	11,44%	10,6%
Betaalde rente ¹	-576	-500	-490	-375	-252	-226,6	-228,8	-210,4
Resultaat voor belastingen (EBT) ¹	4.077	4.968	8.211	8.306	6.664	7.271	8.346	9.639
Variatie	-	21,85%	65,28%	1,16%	-19,77%	9,11%	14,78%	15,5%
Nettowinst (verlies) ¹	3.687	4.471	7.071	6.933	5.723	5.938	6.851	7.805
Variatie	-	21,26%	58,15%	-1,95%	-17,45%	3,75%	15,39%	13,91%
Datum van publicatie	22/01/20	27/01/21	26/01/22	25/01/23	24/01/24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3
Omzet ¹	8.314	7.726	7.328	8.853	10.701	10.456	10.223	10.928	11.468	11.895	11.257	10.410	10.091	9.747	9.978	10.143	10.241	9.964	10.377	10.635	11.041	10.666	11.183	11.418	11.840	11.551	12.015	12.381
Variatie	-	-7,07%	-5,15%	20,81%	20,87%	-2,29%	-2,23%	6,9%	4,94%	3,72%	-5,36%	-7,52%	-3,06%	-3,41%	2,37%	1,65%	0,97%	-2,7%	4,14%	2,49%	3,82%	-3,4%	4,85%	2,1%	3,7%	-2,44%	4,01%	3,05%
EBITDA ¹	2.308	1.697	1.587	2.303	3.464	3.265	2.918	3.369	3.263	4.247	3.300	2.812	2.442	2.372	2.467	2.606	2.743	2.292	2.607	2.730	3.069	2.597	2.930	3.056	3.286	3.033	3.228	3.391
Variatie	-	-26,47%	-6,48%	45,12%	50,41%	-5,74%	-10,63%	15,46%	-3,15%	30,16%	-22,3%	-14,79%	-13,16%	-2,87%	4,01%	5,63%	5,26%	-16,44%	13,74%	4,72%	12,42%	-15,37%	12,81%	4,3%	7,51%	-7,69%	6,43%	5,04%
Bedrijfsresultaat (EBIT) ¹	2.035	1.430	1.315	2.005	3.106	2.840	2.548	3.042	2.894	3.620	2.985	2.495	2.131	2.057	2.165	2.278	2.411	1.959	2.273	2.399	2.702	2.227	2.555	2.686	2.952	2.668	2.897	3.018
Variatie	-	-29,73%	-8,04%	52,47%	54,91%	-8,56%	-10,28%	19,39%	-4,87%	25,09%	-17,54%	-16,42%	-14,59%	-3,47%	5,25%	5,22%	5,84%	-18,75%	16,03%	5,54%	12,64%	-17,6%	14,74%	5,15%	9,88%	-9,61%	8,58%	4,19%
Charge d'intérêts ¹	-139	-121	-125	-127	-127	-124	-123	-123	-120	-117	-106	-86	-66	-52	-61	-69	-70	-61	-58	-51	-56,87	-62,42	-61,42	-60,32	-57,95	-80	-80	-80
Resultaat voor belastingen (EBT) ¹	-	-	-	-	-	2.043	-	-	-	-	-	-	-	1.562	1.636	1.671	1.795	1.436	1.607	1.940	2.082	1.773	2.026	2.150	2.303	2.057	2.304	2.473
Variatie	-	-	-	-	-	-	-100%	-	-	-	-	-	-	-	4,74%	2,14%	7,42%	-20%	11,91%	20,72%	7,29%	-14,82%	14,27%	6,12%	7,12%	-10,68%	11,98%	7,36%
Nettowinst (verlies) ¹	1.049	564	537	1.232	2.158	1.793	1.189	2.100	1.989	2.447	2.018	1.435	1.033	1.318	1.375	1.436	1.594	1.225	1.302	1.646	1.802	1.444	1.707	1.813	2.035	1.770	1.967	2.102
Variatie	-	-46,23%	-4,79%	129,42%	75,16%	-16,91%	-33,69%	76,62%	-5,29%	23,03%	-17,53%	-28,89%	-28,01%	27,59%	4,32%	4,44%	11%	-23,15%	6,29%	26,42%	9,47%	-19,85%	18,19%	6,24%	12,23%	-13,03%	11,12%	6,86%
Datum van publicatie	22/01/20	16/04/20	16/07/20	21/10/20	27/01/21	20/04/21	22/07/21	20/10/21	26/01/22	20/04/22	20/07/22	19/10/22	25/01/23	19/04/23	20/07/23	18/10/23	24/01/24	17/04/24	18/07/24	16/10/24	-	-	-	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Abbott Laboratories

balance-sheet-analysis-chart ABBOTT-LABORATORIES

Fiscaal tijdperk: December	2019	2020	2021	2022	2023	2024	2025	2026
Nettoschuld ¹	13.999	11.909	7.801	6.891	7.783	6.451	5.085	2.274
Variatie	-	-14,93%	-34,49%	-11,67%	12,94%	-17,11%	-21,18%	-55,28%
Datum van publicatie	22/01/20	27/01/21	26/01/22	25/01/23	24/01/24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Abbott Laboratories

Fiscaal tijdperk: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	1.638	2.177	1.885	1.777	2.202	2.103	2.296	2.435
Variatie	-	32,91%	-13,41%	-5,73%	23,92%	-4,5%	9,19%	6,04%
Vrije kasstroom (FCF) ¹	4.498	5.724	8.648	7.804	5.059	9.105	8.892	9.344
Variatie	-	27,26%	51,08%	-9,76%	-35,17%	79,98%	-2,34%	5,08%
Datum van publicatie	22/01/20	27/01/21	26/01/22	25/01/23	24/01/24	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Abbott Laboratories

Fiscaal tijdperk: December	2019	2020	2021	2022	2023	2024	2025	2026
Winstgevendheid
EBITDA-marge (%)	25,66%	26,6%	29,75%	28,6%	25,4%	25,37%	25,8%	26,58%
EBIT-marge (%)	22,29%	23,14%	26,29%	25,73%	22,22%	22,22%	23,12%	23,83%
EBT-marge (%)	12,78%	14,36%	19,06%	19,03%	16,61%	17,31%	18,56%	19,97%
Nettomarge (%)	11,56%	12,92%	16,42%	15,88%	14,27%	14,14%	15,23%	16,17%
FCF-marge (%)	14,1%	16,54%	20,08%	17,88%	12,61%	21,68%	19,77%	19,36%
Vrije kasstroom/nettoresultaat (%)	122%	128,03%	122,3%	112,56%	88,4%	153,35%	129,78%	119,72%
Winstgevendheid
ROA	8,6%	9,33%	9,57%	12,65%	10,57%	9,35%	10,15%	11%
ROE	18,86%	20,52%	27,32%	26,12%	20,73%	20,4%	21,44%	22,26%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,71x	1,29x	0,61x	0,55x	0,76x	0,61x	0,44x	0,18x
Schuld/vrije kasstroom	3,11x	2,08x	0,9x	0,88x	1,54x	0,71x	0,57x	0,24x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	5,13%	6,29%	4,38%	4,07%	5,49%	5,01%	5,11%	5,04%
CAPEX / EBITDA (%)	20%	23,65%	14,71%	14,23%	21,61%	19,74%	19,79%	18,98%
CAPEX / FCF (%)	36,42%	38,03%	21,8%	22,77%	43,53%	23,1%	25,82%	26,06%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	3,445	4,424	5,888	5,431	4,152	5,949	7,016	7,6
Variatie	-	28,4%	33,1%	-7,76%	-23,56%	43,29%	17,93%	8,33%
Dividend per aandeel ¹	1,32	1,53	1,82	1,92	2,08	2,21	2,338	2,536
Variatie	-	15,91%	18,95%	5,49%	8,33%	6,24%	5,81%	8,45%
Nettoactief per aandeel ¹	17,64	18,5	20,3	21,11	22,26	23,18	24,11	25,49
Variatie	-	4,89%	9,7%	4,02%	5,45%	4,12%	4,03%	5,7%
WPA ¹	2,06	2,49	3,94	3,91	3,26	3,423	3,962	4,529
Variatie	-	20,87%	58,23%	-0,76%	-16,62%	4,99%	15,75%	14,33%
Aantal aandelen (in duizend)	1.768.456	1.713.401	1.714.968	1.743.574	1.736.059	1.734.455	1.734.455	1.734.455
Datum van publicatie	22/01/20	27/01/21	26/01/22	25/01/23	24/01/24	-	-	-